$155 Million is the total value of Birchview Capital, LP's 67 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 37.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $47,767,000 | +1.4% | 766,106 | -3.8% | 30.80% | -3.9% |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $941,000 | -31.4% | 60,000 | -25.0% | 0.61% | -34.9% |
| CCXI | Sell | CHEMOCENTRYX INC | $728,000 | +70.1% | 20,000 | -20.0% | 0.47% | +61.2% |
| YTEN | Sell | YIELD10 BIOSCIENCE INC | $92,000 | -18.6% | 18,750 | -0.2% | 0.06% | -23.4% |
| TXMD | Sell | THERAPEUTICSMD INC | $18,000 | -75.7% | 50,000 | -50.0% | 0.01% | -76.0% |
| ARQT | Exit | ARCUTIS BIOTHERAPEUTICS INC | $0 | – | -9,000 | -100.0% | -0.15% | – |
| PROG | Exit | PROGENITY INC | $0 | – | -270,000 | -100.0% | -0.28% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -10,672 | -100.0% | -1.25% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
| QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
| MASIMO CORP | 36 | Q3 2023 | 2.2% |
| PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
| XENCOR INC | 35 | Q3 2023 | 0.4% |
| NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
| CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
| BIOGEN INC | 31 | Q2 2022 | 3.1% |
| CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
| YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
| YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
| HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
| METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3/A | 2024-02-20 |
| 4/A | 2024-02-20 |
| SC 13G/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-04-07 |
| 4 | 2023-03-27 |
| 3 | 2023-02-13 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.